Africa IVD Market Poised to Reach $1.65 Billion by 2031, Driven by Rising Demand for Point-of-Care Diagnostics and Technological Advancements

The increasing prevalence of chronic and infectious diseases, coupled with government initiatives, fuels market growth.

The Africa in-vitro diagnostics (IVD) market is projected to grow significantly, reaching $1.65 billion by 2031, with a compound annual growth rate (CAGR) of 3.1% from 2024 to 2031, according to a new report by Meticulous Research®. This growth is driven by increasing investments from global IVD players, rising healthcare expenditures, and the growing adoption of point-of-care (POC) diagnostics in the region.

Africa continues to grapple with a high burden of infectious diseases, ranging from emerging pathogens like Rickettsia felis and Tropheryma whipplei to well-known historical diseases like cholera. Additionally, the continent has experienced outbreaks of previously unknown viruses, including Ebola, Zika, and Chikungunya, which have had profound impacts on public health. The increasing prevalence of diseases such as HIV/AIDS is also a significant factor in driving demand for IVD technologies.

Download Complete Sample PDF Copy Here:  https://www.meticulousresearch.com/download-sample-report/cp_id=5415

According to HIV.gov, as of 2022, the number of people living with HIV in eastern and southern Africa reached 20.8 million, with new infections continuing to rise. The availability of rapid diagnostic and self-testing kits has been a critical factor in curbing the spread of HIV, further contributing to the growth of the IVD market.

Advanced IVD Technologies Address Africa’s Infectious Disease Burde

IVD technologies, including immunoassays, molecular diagnostics, clinical chemistry, and microbiology, play a vital role in tackling Africa’s infectious disease challenges. Innovations such as next-generation sequencing (NGS), molecular systems, and POC diagnostics enable healthcare professionals to accurately diagnose diseases and improve prognosis. The growing demand for early detection and rapid diagnostics is a key factor in the increasing adoption of IVD products.

Government Initiatives Boosting Healthcare Infrastructure

Governments across Africa are actively working to strengthen healthcare systems in collaboration with global organizations and developed nations. Frequent disease outbreaks, technological advancements, and the growing need for early diagnosis have prompted governments to modernize healthcare facilities.

Check complete table of contents with list of table and figures: https://www.meticulousresearch.com/product/africa-ivd-market-5415

For example, the U.S. Agency for International Development (USAID) and the U.S. Centers for Disease Control and Prevention (CDC) reported a 15.3% increase in U.S. President’s Malaria Initiative (PMI)-supported health facilities between 2016 and 2020. In another instance, the U.S. Embassy in Nairobi announced $345 million in funding through the PEPFAR program to bolster Kenya’s HIV response. These initiatives are critical in improving healthcare access and expanding the adoption of IVD products across Africa.

Point-of-Care Diagnostics: A Key Trend in Africa’s Healthcare Landscape

POC testing is increasingly being embraced across Africa due to its affordability, ease of use, and ability to deliver quick results. Given the region’s economic and infrastructural challenges, POC diagnostics play a crucial role in providing timely and accurate disease detection. In particular, POC testing is essential in diagnosing conditions like HIV, hepatitis, and syphilis, where rapid results are vital.

The prevalence of HIV remains a major concern, especially among young women and adolescent girls in sub-Saharan Africa, who accounted for over 77% of new HIV infections in 2022, according to UNAIDS. The rising demand for rapid diagnostics in this demographic is driving market growth for POC solutions.

Industry collaborations are also playing a pivotal role in advancing POC adoption. For example, Siemens Healthineers partnered with UNICEF in 2022 to optimize POC networks across Africa. Events like MEDLAB Africa, held in Lagos in 2024, further highlight the significance of POC diagnostics in enhancing healthcare outcomes in the region.

Quick Buy: https://www.meticulousresearch.com/Checkout/47708335

Market Insights and Key Players

Meticulous Research® provides an in-depth analysis of the Africa IVD market, highlighting key growth drivers, challenges, and opportunities. South Africa is expected to hold a significant market share in 2024, with major players such as Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Illumina, Inc. (U.S.) leading the market across Africa.

These companies are expanding their presence in Africa, either directly or through distributors, driving the widespread adoption of IVD products and contributing to market growth.

Conclusion

The high prevalence of infectious diseases, alongside government-led healthcare initiatives, is driving demand for innovative IVD technologies across Africa. As molecular diagnostics, POC testing, and next-generation sequencing gain traction, the IVD market presents lucrative opportunities for both existing players and new entrants.

For more information on the Africa IVD market, please download the full report at [https://www.meticulousresearch.com/download-sample-report/cp_id=5415].

Contact Us:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research